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Abstract. 
 
The ADAMs (a disintegrin and metallopro-
tease) family of proteins is involved in a variety of cel-
lular interactions, including cell adhesion and ecto-
domain shedding. Here we show that ADAM 12 binds 
to cell surface syndecans. Three forms of recombinant 
ADAM 12 were used in these experiments: the cys-
teine-rich domain made in 
 
Escherichia coli 
 
(rADAM
12-cys), the disintegrin-like and cysteine-rich domain 
made in insect cells (rADAM 12-DC), and full-length 
human ADAM 12-S tagged with green ﬂuorescent pro-
tein made in mammalian cells (rADAM 12-GFP). Mes-
enchymal cells speciﬁcally and in a dose-dependent 
manner attach to ADAM 12 via members of the synde-
can family. After binding to syndecans, mesenchymal 
cells spread and form focal adhesions and actin stress ﬁ-
bers. Integrin 
 
b
 
1 was responsible for cell spreading be-
cause function-blocking monoclonal antibodies com-
pletely inhibited cell spreading, and chondroblasts 
lacking 
 
b
 
1 integrin attached but did not spread. These 
data suggest that mesenchymal cells use syndecans as 
the initial receptor for the ADAM 12 cysteine-rich do-
main–mediated cell adhesion, and then the 
 
b
 
1 integrin 
to induce cell spreading. Interestingly, carcinoma cells 
attached but did not spread on ADAM 12. However, 
spreading could be efﬁciently induced by the addition 
 
of either 1 mM Mn
 
2
 
1
 
 or the 
 
b
 
1 integrin–activating
monoclonal antibody 12G10, suggesting that in these 
carcinoma cells, the ADAM 12–syndecan complex fails 
to modulate the function of 
 
b
 
1 integrin.
Key words: ADAM • syndecan • integrin • cell adhe-
sion • receptor cross-talk
 
Introduction
 
Control of cell adhesion is important in several biological
phenomena, including embryonal development and tumor
cell invasion and metastasis (Damsky and Werb, 1992; Ya-
mada and Geiger, 1997; Couchman and Woods, 1999; Gi-
ancotti and Ruoslahti, 1999). Understanding the molecular
mechanisms of these processes requires information about
a variety of extracellular ligands, their interaction with cell
membrane receptors, and the subsequent downstream sig-
nal cascade. One class of cell adhesion receptors is the in-
tegrins that often work in cooperation with other cell sur-
face molecules. Integrin 
 
a
 
5
 
b
 
1–mediated cell adhesion of
cultured fibroblastic cells to fibronectin requires synde-
can-4 as a coreceptor (Saoncella et al., 1999), and the cell
surface chondroitin sulfate proteoglycan NG2 cooperates
with 
 
a
 
4
 
b
 
1 in mediating melanoma cell adhesion and
spreading (Eisenmann et al., 1999). Similarly, multimolec-
ular receptor adhesion complexes have been described for
tetraspan molecules and integrins (Hemler, 1998).
The ADAMs
 
1
 
 (a disintegrin and metalloprotease) con-
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Abbreviations used in this paper:
 
 ADAM, a disintegrin and metallopro-
tease; GFP, green fluorecent protein; rADAM 12-cys, recombinant cys-
teine-rich domain of human ADAM 12; rADAM 12-DC, recombinant
disintegrin-like and cysteine-rich domain of mouse ADAM 12; rADAM
12-GFP, recombinant full-length ADAM 12-S tagged with GFP; RT, re-
verse transcription; SVMP, snake venom metalloprotease; TDM, triple
deletion mutant. 
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stitute a recently discovered family of cell adhesion recep-
tors (Wolfsberg and White, 1996; Blobel, 1997; Black and
White, 1998; Schlöndorff and Blobel, 1999; Stone et al.,
1999; Primakoff and Myles, 2000). Over 20 members have
been described so far (see http://www.med.virginia.edu/
 
z
 
jag6n/whitelab.html). Most members are composed of
pro-, metalloprotease, disintegrin-like, cysteine-rich, EGF-
like repeat, transmembrane, and cytoplasmic tail domains.
One important role of ADAMs relates to their metallo-
protease activity (Black and White, 1998; Schlöndorff
and Blobel, 1999). A well-studied example is ADAM 17
(TACE), which functions in cell surface shedding of a
number of growth factors, including tumor necrosis fac-
tor-
 
a
 
 (TNF
 
a
 
), transforming growth factor-
 
a
 
 (TGF
 
a
 
), and
Notch (Black et al., 1997; Moss et al., 1997; Peschon et al.,
1998; Brou et al., 2000). Another important role of the
ADAMs relates to cellular interactions, as shown for ferti-
lin 
 
a
 
 and 
 
b
 
 (ADAM 1 and 2) in sperm–egg binding and fu-
sion during fertilization (Almeida et al., 1995; Chen et al.,
1999a,b). However, the molecular mechanisms of the
ADAMs in cellular interactions are not well-understood.
We have recently described the cloning of secreted and
transmembrane forms of human ADAM 12 (Gilpin et al.,
1998) that are implicated in myoblast fusion (Yagami-
Hiromasa et al., 1995) and myogenesis (Gilpin et al., 1998).
Human ADAM 12 is an active metalloprotease containing
the highly conserved zinc-binding catalytic motif HEXGH-
XXGXXHD (Loechel et al., 1998, 1999). ADAM 12 ex-
pression is upregulated in cancer, and in several tumors
ADAM 12 immunostaining is enriched along the tumor
cell surfaces (Iba et al., 1999). Based on this intriguing tis-
sue distribution pattern, we asked whether ADAM 12 was
involved in cell adhesion. We found that the recombinant
cysteine-rich domain of human ADAM 12 made in 
 
E. coli
 
(rADAM 12-cys) supports carcinoma cell adhesion but
fails to promote cell spreading (Iba et al., 1999). In this
study, we explored the molecular mechanisms underlying
this type of cell adhesion. We found that mesenchymal
cells attach, spread, and form focal adhesions and organize
stress fibers in response to ADAM 12, and that both syn-
decans and integrins are necessary to mediate these pro-
cesses. Carcinoma cells, on the other hand, bind to synde-
cans but do not spread or engage 
 
b
 
1 integrins in the
ADAM 12–mediated adhesion process. However, they
can be induced to spread by addition of either 1 mM Mn
 
2
 
1
 
or the 
 
b
 
1 integrin–activating mAb 12G10.
 
Materials and Methods
 
Antibodies
 
Integrin 
 
b
 
1 function-blocking mAbs rat IgG
 
1
 
 AIIB2 and mouse IgG2b
CSAT were obtained from the Developmental Studies Hybridoma Bank
maintained by the University of Iowa, Department of Biological Sciences.
Another integrin 
 
b
 
1 function-blocking mAb (clone P5D2) was obtained
from Chemicon. The 
 
b
 
1 function-activating mAb 12G10 (Mould et al.,
1995) was kindly provided by M. Humphries (University of Manchester,
Manchester, UK) and an integrin 
 
b
 
1 mAb (K20) with no reported effect
on cell function was obtained from Immunotech. Rat IgG
 
1
 
 mAb to mouse
tetranectin (Wewer et al., 1998) was used as an isotype Ig control for the
AIIB2. Function-blocking mAbs to integrin 
 
a
 
1 (clone H22B6), 
 
a
 
2 (clone
Gi9), and 
 
a
 
5 (clone SAM1) were obtained from Immunotech, and mAbs
to integrin 
 
a
 
3 (P1B5) was obtained from Life Technologies. Function-
blocking mAb to integrin 
 
a
 
6 (clone 135.13C) was kindly provided by
A. Mercurio (Beth Israel Hospital, Harvard, Boston, MA). For immu-
nostaining of focal adhesions, mAb to vinculin (kindly provided by M.
Glukhova, Institut Curie, Paris, France) was used. Tetramethyl rho-
damine isothiocyanate-phalloidin was obtained from Molecular Probes
and used to stain actin. mAbs to syndecan-1 (281-2) (Jalkanen et al., 1985;
Liebersbach and Sanderson, 1994) and to glypican-1 (kindly provided by
A.D. Lander, University of California Irvine, Irvine, CA) (Litwack et al.,
1998) were used to stain transfected ARH-77 cells. For Western blotting,
a pan-syndecan antiserum that reacts with all syndecans (kindly provided
by A.C. Rapraeger, University of Wisconsin, Madison, WI) (Reinland et
al., 1996; Ott and Rapraeger, 1998) and an antiserum to human syndecan-4
(Kojima et al., 1996) were used. To confirm the identity of the recombi-
nant ADAM 12 fragments by Western blotting, two rat mABs, 14E3 to
the cysteine-rich domain (Gilpin et al., 1998) and a newly developed 2F7
to the disintegrin-like domain, were used. The 2F7 mAb was generated
and characterized as described previously using recombinant ADAM 12
aa 412–557 polypeptide expressed in 
 
E. coli
 
 as an antigen (Gilpin et al.,
1998). IgGs were purified using protein G–Sepharose as described by the
manufacturer (Amersham Pharmacia Biotech). Fluorescein- and rho-
damine-conjugated antibodies against rabbit, rat, and mouse Igs were pur-
chased from DAKO.
 
Cell Lines
 
Except when specified, cell lines were obtained from American Type Cul-
ture Collection. The following human cell lines were used: RKO colon
carcinoma (kindly provided by A. Mercurio, Boston, MA), MDA-MB-231
breast carcinoma (HTB26), RD rhabdomyosarcoma (CCL 136), SV-HFO
human fetal osteoblasts transformed with simian virus 40 virus (Chiba et
al., 1993), MG-63 osteosarcoma (CRL 1427), Saos-2 osteogenic sarcoma
(HTB 85), HOS osteogenic sarcoma (CRL 1543), MRC-5 lung fibroblast
(CCL 171), IMR-90 lung fibroblast (CCL 186), WI-38 lung fibroblast
(CCL 75), and CCD 1072SK foreskin fibroblast (CRL 2088). In addition,
the murine osteoblastic MC3T3-E1 cell line was used (Sudo et al., 1983).
These cell lines were grown in DME, supplemented with glutamax I and
4,500 mg/ml glucose and 10% FBS. The human ARH-77 B-lymphoid cell
line and a series of ARH-77–transfected cell lines (Neo, Syn-1, -2, -4, Syn/
279t, Syn/Glyp, Glyp/Syn, Glyp-1, and triple deletion mutant [TDM])
(Langford et al., 1998; Liu et al., 1998) were grown in suspension in RPMI
1640 medium with glutamax I supplemented with 5% FBS. All media
used in this study were supplemented with 50 U/ml penicillin, 50 
 
m
 
g/ml
streptomycin, and the cells were grown in Nunc tissue culture flasks
(GIBCO BRL) at 37
 
8
 
C in 5% CO
 
2
 
 in a humidified atmosphere.
 
Isolation of Primary Osteoblast and Muscle Cells from 
Mice and Chicken
 
NMRI mice were obtained from M & B and white Italian 
 
3
 
 Isabraum, F1
chicken embryos from Statens Serum Institut.
Primary mouse osteoblast-like cells were isolated from calvaria of new-
born (0–3-d-old) NMRI mice using an enzyme mixture containing 0.32
mg/ml collagenase (Sigma C 5894) and 0.25% trypsin (GIBCO BRL) es-
sentially as described (Bellows et al., 1986; Otto et al., 1996). The cells
were grown in DME and 10% FBS. The osteogenic capacity of the cells
was tested by their ability to deposit minerals. In brief, the cells were
grown in above standard medium supplemented with 50 
 
m
 
g/ml ascorbic
acid (Sigma A 2147) and 10 mM 
 
b
 
-glycero-phosphate (Sigma G 9891).
Mineralization was observed after 10–14 d, and mineralized foci were
stained by Alizarin red S (Sigma A 5533) after 21 d in culture.
Primary mouse muscle cells were isolated from the hindlimb muscle of
newborn (0–3-d-old) mice using an enzyme mixture of 0.15% trypsin and
0.1% dispase (both enzymes from GIBCO BRL) essentially as described
(Allen et al., 1984; DiMario and Strohman, 1988; Partridge, 1997). The
cells were cultured in DME with 20% FBS and 2% chick embryo extract.
Subconfluent cell cultures were passaged and some cultures were changed
to DME with 2% horse serum to confirm the ability of the myoblasts to
differentiate and form contracting myotubes.
Primary chicken muscle cell cultures were prepared from 11-d-old
chick embryo breast muscle using 0.25% trypsin essentially as described
(Bischoff and Holtzer, 1969; Knudsen and Horwitz, 1977).
 
Isolation of Normal and 
 
b
 
1-Deficient Chondroblasts 
from Mice Carrying a Conditional Null Mutation in the 
 
b
 
1 Integrin Gene
 
Chondroblast cell lines with a deletion of the 
 
b
 
1 integrin gene were estab- 
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lished using mice with a loxP-tagged (floxed) 
 
b
 
1 integrin gene (Potocnik).
Chondroblasts were isolated from 3-d-old pups of homozygously floxed
mice and immortalized by infection with a retrovirus transducing a heat-
labile variant of the simian virus 40 large T antigen (kindly provided by P.
Sharp, Massachusetts Institute of Technology, Cambridge, MA). These
 
1
 
c
 
/
 
1
 
c
 
 cells were subsequently infected with an adenovirus transducing the
cre-recombinase (Anton and Graham, 1995), resulting in excision of the
 
b
 
1 integrin gene in infected cells. 
 
b
 
1 integrin–null cells (
 
2
 
/
 
2
 
) were puri-
fied by FACS and further cultured. FACS sorted 
 
b
 
1 integrin–expressing
cells, in which no or only one allele of the 
 
b
 
1 integrin gene was deleted,
served as control cells.
For FACS analysis, cells were briefly trypsinized, washed with growth
medium, and resuspended in ice-cold PBS containing 1% BSA. Staining
for 
 
b
 
1 integrin was carried out in the same buffer using FITC-labeled
mAb Ha2/5 (PharMingen). Cell sorting was done using a FACSvantage,
and analytical stainings were analyzed with a FACSort (Beckton Dick-
inson).
 
Morphological and Immunocytochemical Analysis
 
To detect focal adhesions, cells were fixed at room temperature for 10 min
in 4% paraformaldehyde in PBS containing 2 mM MgCl
 
2
 
 and permeabi-
lized with 0.1% Triton X-100 in DME with 15% FBS for 5 min at room
temperature. After rinsing and blocking for 30 min in DME with 15%
FBS, vinculin antibodies supplied as culture medium supernatant were di-
luted (1:10) in DME with 2% BSA and incubated with the cells for 30 min
followed by a thorough rinse and incubation with secondary antibodies.
The actin cytoskeleton was visualized by tetramethyl rhodamine isothio-
cyanate-phalloidin staining as recommended by the manufacturer. For im-
munostaining of cell surface syndecan-1 and glypican-1, ARH-77 cell
suspensions were rinsed in culture medium and incubated with FITC-con-
jugated mAb 281 against syndecan-1 or anti–glypican 1 antiserum (10 
 
m
 
g/
ml) followed by a second antibody. Cells were examined using an inverted
microscope (Zeiss Axiovert) equipped with phase contrast optics and con-
nected to a PentaMAX chilled charge-coupled device camera (Princeton
Instruments, Inc.).
 
Cell Attachment Assays
 
The attachment assay was performed as described previously (Iba et al.,
1999). Substrates included purified rADAM 12-cys, disintegrin-like do-
main (rADAM 12-disintegrin), metalloprotease domain (rADAM 12-
metallo) made in 
 
E. coli
 
 (Iba et al., 1999), purified recombinant mouse
disintegrin-like and cysteine-rich domain (rADAM 12-DC) made in insect
cells (Zolkiewska, 1999), and for comparison, mouse laminin-1 from the
EHS tumor, human laminin-10/11, and human fibronectin (GIBCO
BRL). BSA was used as a negative control. Nunc-Immuno™ 96-well
plates with MaxiSorp™ surface (Nunc) were coated with 1–50 
 
m
 
g/ml of
the substrates in 0.1 M NaHCO
 
3
 
 buffer, pH 9.5, overnight at 4
 
8
 
C, rinsed
with PBS, and incubated with 10 mg/ml BSA in PBS for 1 h at 37
 
8
 
C. After
a rinse with PBS, 100 
 
m
 
l of the cell suspension (0.6 
 
3
 
 10
 
6
 
/ml) was added to
the wells for 1 h at 37
 
8
 
C in 5% CO
 
2
 
 in a humidified atmosphere. The wells
were rinsed twice in serum-free DME, fixed for 20 min in 2% glutaralde-
hyde in 0.1 M cacodylate buffer, pH 7.2, rinsed in PBS and stained with
0.1% crystal violet in 10% methanol (vol/vol). Absorbance was measured
with a Multiscan ELISA reader (Labsystems) at 590 nm. A blank value
corresponding to an empty well was automatically subtracted. Each assay
point was derived from three to six separate wells and repeated three
times.
The following experimental conditions were tested: (a) The cells were
grown in sulfate-free Fischer’s medium containing 10% dialyzed FBS in
the presence of 20 mM sodium chlorate (Sigma C 3171), or in both sodium
chlorate and 10 mM sodium sulfate as a control (Baeuerle and Huttner,
1986; Keller et al., 1989), for 24 h before the assay. (b) Plates were prein-
cubated with heparin (Sigma H 2149), heparan sulfate (Sigma D 9808),
heparin-albumin (Sigma H 0403), chondroitin sulfate A, B, and C, respec-
tively (Sigma C 9819, C 0320, C 4384), or hyaluronic acid (Sigma H 1751)
at the concentrations indicated. Alternatively, these compounds were
added in solution during the incubation period. (c) The cells were pre-
treated for 30 min with 2 mU/ml heparitinase or 50 mU/ml protease-free
chondroitinase ABC (#100703 and 100332, respectively; Seikagaku Corp.).
(d) The cells were preincubated for 15 min at room temperature with 10
 
m
 
g/ml of function-blocking mAbs to human integrin 
 
b
 
1 (A2BII or P5D2),
integrin 
 
a
 
1, 
 
a
 
2, 
 
a
 
3, 
 
a
 
5, 
 
a
 
6 (H22B6, Gi9, PIB5, SAM 1, and 135.13C), or as
an isotype control, with 10 
 
m
 
g/ml IgG
 
1
 
 rat mAbs to tetranectin (1B11). For
experiments with chicken muscle cells, the CSAT mAb was used. (e) Cy-
 
cloheximide (Sigma C 7698) was added at 25 
 
m
 
g/ml for 3 h before the as-
say period to inhibit protein synthesis. (f) Cytochalasin B (Sigma C 6762)
or D (Sigma C 8273) dissolved in DMSO was added at 20 and 0.1 
 
m
 
M, re-
spectively. Unless otherwise indicated, the various reagents were present
throughout the 1-h attachment assay period.
To test for induction of cell spreading, a modification of the above
mentioned attachment assay was employed. The cells were allowed to at-
tach for 30 min and then Mn
 
2
 
1
 
 (0.1 or 1 mM MnCl
 
2
 
) or 10 
 
m
 
g/ml of the 
 
b
 
1
integrin mAbs (12G10 or K20) was added for another 30 min.
 
Cell Binding Assay with Green Fluorescent
Protein–tagged Human ADAM 12-S
 
An expression construct for full-length human ADAM 12-S fused at the
COOH terminus to green fluorescent protein (GFP) was constructed us-
ing the pEGFP-N1 from CLONTECH Laboratories, Inc. A DNA frag-
ment containing the entire coding region of ADAM 12-S (pro-, metallo-
protease, disintegrin-like, cysteine-rich, EGF-like repeat domains, and the
33–amino acid COOH tail; sequence data available from EMBL/Gen-
Bank/DDBJ under accession no. AF023477) was generated by PCR using
 
Pfu
 
 DNA polymerase (Stratagene) and inserted at the EcoR1/SacII sites
of pEGFP-N1, such that the COOH terminus of ADAM 12 was in-frame
with GFP. A control plasmid for secretion of GFP alone was made by
transferring the EcoR1/Not1 GFP cassette from pEGFP-N1 to the plas-
mid pSecTagA (Invitrogen Corp.), resulting in expression of a GFP
polypeptide fused at the NH
 
2
 
 terminus to an Ig
 
k
 
 leader sequence. COS-7
cells were transiently transfected as described previously (Loechel et al.,
1998, 1999), the culture medium collected 2 d later, and any cellular debris
removed by centrifugation. ARH-77 cells (5 
 
3
 
 10
 
5
 
) expressing syndecan-1
or -4 or control ARH-77 cells transfected with an empty vector (neo) were
incubated with 1 ml of human ADAM 12-GFP or GFP-containing culture
medium. After 1 h incubation at 37
 
8
 
C or at 4
 
8
 
C, the cells were examined
by fluorescence microscopy. In other control experiments, heparin was
added to the incubation medium or the cells were pretreated with hep-
aritinase.
 
RNA Extraction and Reverse Transcription (RT)-PCR
 
Total RNA was purified using the TRIzol reagent (GIBCO BRL). For the
reverse transcriptase reaction, the cloned mouse Moloney leukemia virus
reverse transcriptase was used as recommended by the manufacturer
(Stratagene). Aliquots of cDNA were amplified using the following prim-
ers: human syndecan-1 (forward) 5
 
9
 
-GCTCTGGGGATGACTCTGAC-
3
 
9 
 
and (backward) 5
 
9
 
-GTATTCTCCCCCGAGGTTTC-3
 
9
 
; human synde-
can-2 (forward) 5
 
9
 
-ACATCTCCCCTTTGCTAACGGC-3
 
9 
 
and (back-
ward) 5
 
9
 
-TAACTCCATCTCCTTCCCCAGG-3
 
9
 
; and human syndecan-4
(forward) 5
 
9
 
-GTCTGGCTCTGGAGATCTGG-3
 
9 
 
and (backward) 5
 
9
 
-
TGGGGGCTTTCTTGTAGATG-3
 
9
 
.
After an initial denaturation at 95
 
8
 
C for 40 s, 35 cycles of denaturation
at 94
 
8
 
C for 40 s, annealing at 55
 
8
 
C for 40 s, and extension at 72
 
8
 
C for 60 s
were carried out. The reaction products were separated on agarose gels.
The amplified DNA fragments (syndecan-1, 552 bp; syndecan-2, 539 bp;
and syndecan-4, 397 bp) were cloned and sequenced to confirm the iden-
tity of the PCR products.
 
Western Blotting of Syndecans
 
Extraction, isolation, and Western blotting of syndecans were performed
as described previously (Lebakken and Rapraeger, 1996). In brief, RD
cells were grown to subconfluence, extracted in 8 M urea, 0.1% Triton
X-100, 10 mM Tris-HCl, and 1 mM Na
 
2
 
SO
 
4 
 
and incubated with DEAE
Sephacel in buffer overnight. The beads were washed and proteins eluted
with 1 M NaCl in heparitinase buffer followed by digestion with hepariti-
nase and chondroitinase. The samples were separated by SDS-PAGE and
immunoblotting performed using the pan-syndecan antibody.
 
Biotinylation of Cell Surface Proteins and Isolation of 
rADAM 12-cys Binding Proteins
 
To identify which cell surface proteoglycans bind to rADAM 12-cys, an
affinity chromatography protocol devised by Hoffman et al. (1998) was
employed. In the Hoffman et al. protocol, urea was used in both extrac-
tion and running buffer, as the attempt to use either octyl glucoside or Tri-
ton X-100 were unsuccessful, apparently because syndecans are insoluble
in these lysis buffers and precipitate with the cytoskeleton. RD cells were 
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washed in PBS, incubated with Ez-Link sulfo NHS-LC-biotin (#21335;
Pierce Chemical Co.) at a final concentration of 100 mg/ml for 1 h at room
temperature, washed twice with 50 mM ammonium chloride to quench the
free biotin, and washed once in PBS. Cell pellets were resuspended and
lysed with a dounce homogenizer in 10 mM KCl, 20 mM Tris-HCl, pH 7.4,
0.1% b-mercaptoethanol, 1 mM EDTA (1 ml/108 cells). After removal of
the nuclei by centrifugation at 1,500 g for 5 min, NaCl was added to the su-
pernatant at a final concentration of 0.15 M and the supernatant centri-
fuged at 50,000 g for 30 min at 48C. The pellet was solubilized in 1 ml of
8 M urea, 2% Triton X-100, 2 mM PMSF in TBS, pH 7.4, and centrifuged
at 14,000 g for 20 min at 48C to remove insoluble matter. The resulting cell
membrane protein solution was incubated with a rADAM 12-cys affinity
matrix (rADAM 12-cys coupled to CnBr-activated Sepharose following
the manufacturer’s instructions) in 6 M urea, 1% Triton X-100, 2 mM
PMSF in TBS, pH 7.4, (running buffer) overnight at 48C under gentle ro-
tation. After a thorough rinse in running buffer, elution was carried out in
20 mM EDTA. The eluted fractions were precipitated with acetone,
washed with ethanol, and resuspended, and part of the material was di-
gested with heparitinase (0.1 U/ml) and/or chondroitinase ABC (1 U/ml)
at 378C for 4 h in the presence of aprotinin (2.2 mg/ml), leupeptin (1 mg/
ml), pepstatin A (2 mg/ml), and EDTA (5 mM). Undigested and digested
material was separated on a 4–12% SDS-PAGE and transferred to Hy-
bond-P (polyvinylidene difluoride) paper (Amersham Pharmacia Bio-
tech). The paper was subsequently blocked in 50 M Tris, 0.5 M NaCl,
0.1% Tween 20, 5% nonfat milk powder, and incubated with peroxidase-
conjugated streptavidin at a final concentration of 1 mg/ml or with a spe-
cific polyclonal antiserum to human syndecan-4 (Kojima et al., 1996),
followed by a peroxidase-conjugated goat anti–rabbit IgG secondary anti-
body. The blots were developed using the chemiluminescence SuperSignal
kit from Pierce Chemical Co.
Purification of Human Syndecan-4 and Solid-phase 
Binding Assay
Native human syndecan-4 ectodomain was purified from the culture me-
dium supernatant of endothelium-like Eahy926 cells under nondenaturat-
ing conditions and iodinated as described (Kojima et al., 1996). The solid-
phase binding assay was used as described previously (Kojima et al.,
1996). In brief, microtiter wells were coated with 5 mg/ml of the basic fi-
broblast growth factor (bFGF) or 50 mg/ml rADAM 12-cys in 100 ml of 50
mM NaHCO3, pH 9.2, overnight at 48C, incubated with 1% BSA in PBS at
room temperature to block nonspecific binding, and incubated with 125I-
labeled human syndecan-4 (800 cpm) in 100 ml of 0.1% BSA overnight at
48C. After rinsing the wells, the amount of bound material was deter-
mined using an Aloka g-counter (Aloka Co. Ltd.).
Results
Mesenchymal Cells Attach, Spread, Form Focal 
Adhesions, and Reorganize Actin Stress Fibers in 
Response to rADAM 12-cys
In a previous report, we showed that carcinoma cells at-
tach but do not spread on rADAM 12-cys (Iba et al.,
1999). Here we examine the molecular mechanism result-
ing in cell adhesion of a number of different cell types
on human rADAM 12-cys made in E. coli and mouse
rADAM 12-DC made in insect cells. In our assays, we
tested cells of osteoblastic origin such as SV-HFO, HOS,
Saos-2, MG-63, MC3T3-E1 cell lines, and primary murine
osteoblasts; fibroblastic cells such as MRC-5, WI-38, IMR-
90, and CCD1072SK; myoblastic cells such as RD cells and
primary murine and chicken muscle cells. Each of these
mesenchymal cell lines attached and .90% of the cells
displayed a spread and flattened morphology on rADAM
12-cys (Fig. 1 A). A similar adhesion pattern was observed
when the cells were plated on laminin or fibronectin (not
shown). Cell attachment was specific and dose-dependent,
and reached a maximum at z15–25 mg/ml (Fig. 1, B and
C). Cells attached efficiently to rADAM 12-DC (Fig. 1 C),
Figure 1. Mesenchymal cell attachment and spreading in re-
sponse to rADAM 12-cys. (A) Cell attachment of MG-63 cells
plated on rADAM 12-cys (20 mg/ml). Bar, 16 mm. (B) Dose-
dependent cell attachment of SV-HFO (filled circles) and RD
cells (open circles) plated on rADAM 12-cys. (C) Cell attach-
ment of the SV-HFO cell line plated on rADAM 12-cys,
rADAM 12-disintegrin, rADAM 12-metallo, rADAM 12-DC,
laminin-1, and fibronectin (20 mg/ml). BSA represents the back-
ground value when no substrate was added. Ordinates represent
OD values at 590 nm, and abscissa the concentration of the sub-
strate in mg/ml as indicated. Each point represents the mean 6
SEM of triplicate wells.Iba et al. ADAM 12 in Cell Adhesion 1147
but cell spreading appeared less efficient than on rADAM
12-cys at equimolar concentrations. No cell attachment
was observed on either the disintegrin-like or the metallo-
protease domains made in E. coli. (Fig. 1 C). The fully
spread mesenchymal cells formed focal adhesions and
contained an elaborate actin cytoskeleton when plated on
rADAM 12-cys (Fig. 2). Cell spreading and stress fiber
formation was decreased by treatment of the cells with
cytochalasin B and D, inhibitors of actin polymerization
(not shown). These results demonstrate that in contrast to
carcinoma cells, which attach but fail to spread, mesenchy-
mal cells attach, spread, form specialized adhesion struc-
tures, and reorganize the actin cytoskeleton in response to
rADAM 12-cys.
Syndecans Serve as Primary Attachment Receptors for 
rADAM 12-cys
We next determined which class of cell adhesion receptors
mediates adhesion to rADAM 12-cys and rADAM 12-
DC. Since we found previously that attachment of carci-
noma cells was dependent on heparan sulfate chains (Iba
et al., 1999) and that CHO cells deficient in heparan sul-
fate synthesis (CHO pgsD-677) were unable to attach to
rADAM 12-cys (Iba, K., and U.M. Wewer, unpublished
results), several compounds interfering with the function
of cell surface heparan sulfates were tested in adhesion as-
says (Fig. 3 A). First, mesenchymal cells were depleted of
functional cell surface proteoglycans by growing them in
the presence of 20 mM sodium chlorate, which inhibits sul-
fation of cell surface glycosaminoglycans. Chlorate-treated
mesenchymal cells were unable to attach to rADAM 12-
cys (Fig. 3 A), but retained their ability to adhere to lami-
nin (not shown). Thus, the lack of cell attachment on
rADAM 12-cys was not due to chlorate-induced cytotoxic-
ity. The inhibitory effect of sodium chlorate on cell attach-
ment was restored by including 10 mM sodium sulfate in
the chlorate-containing culture medium (not shown). Sec-
ondly, cell attachment was significantly inhibited when
heparin or heparan sulfate was included in the assays. Sim-
ilarly, cell attachment to rADAM 12-DC was inhibited by
heparin (Fig. 3 B). In contrast, hyaluronic acid or chon-
droitin sulfate ABC did not interfere with cell adhesion
(Fig. 3 A). Heparin was very potent in inhibiting cell at-
tachment. For most of the cell lines tested, 1 mg/ml heparin
reduced cell attachment to 50%, and 10–20 mg/ml led to a
complete inhibition (not shown). The only exception was
RD rhabdomyosarcoma cells, which exhibited only a par-
tial inhibition of cell attachment when assays were per-
formed in the presence of heparin but almost a complete
inhibition (90%) when heparin was administered in the
form of heparin-albumin (not shown). Thirdly, removal of
cell surface heparan sulfate chains by pretreatment of the
cells with heparitinase reduced cell attachment, whereas
chondroitinase ABC had no effect (not shown). No effect
on cell attachment was observed when cells were pre-
treated with b1 integrin function-blocking mAbs (Fig. 3
A). These results demonstrate that attachment of mesen-
chymal cells to rADAM 12-cys and rADAM 12-DC was
critically dependent on cell surface heparan sulfate.
To identify the nature of the heparan sulfate proteo-
glycan, which provides the heparan sulfate chains for
rADAM 12-cys– and ADAM 12-DC–mediated cell adhe-
sion, we took advantage of the ARH-77 B lymphoid cell
system (Langford et al., 1998; Liu et al., 1998). The ARH-
77 cell line, which was derived from a human plasma cell
leukemia, expresses very little heparan sulfate on the cell
surface. However, when transfected with cDNAs encoding
members of the syndecan family, these ARH-77 cells ex-
press functional cell surface syndecans that bear heparan
sulfate chains (Langford et al., 1998; Liu et al., 1998). A se-
ries of stably transfected cell lines that express either syn-
decans-1, -2, or -4, or glypican-1 on their cell surface (Liu
et al., 1998) were tested in a cell adhesion assay (Fig. 4 A).
As expected, the parental ARH-77 cells transfected with
vector only (ARH-77 neo) did not attach to rADAM 12-
cys. Cells transfected with either syndecan-1,-2, or -4 at-
Figure 2. Focal adhesion formation and reorganization of the ac-
tin cytoskeleton in response to rADAM-cys. (A) SV-HFO cells
plated on rADAM 12-cys and stained with mAbs to vinculin.
Numerous distinct focal adhesions are seen. (B) SV-HFO cells
plated on rADAM 12-cys and stained with phalloidin to detect
F-actin. An elaborate organization of stress fibers is evident.
Bars, 6 mm.The Journal of Cell Biology, Volume 149, 2000 1148
tached to rADAM 12, but did not spread, whereas glypi-
can-1–transfected cells did not attach. Similarly, ARH-77
cells expressing syndecan-1 also attached to rADAM 12-
DC (Fig. 4 B). Adhesion of syndecan-1–transfected cells
to rADAM 12-cys (Fig. 4 C) or rADAM 12-DC (not
shown) is blocked by compounds that interfere with the
function of heparan sulfate chains. Moreover, cells ex-
pressing syndecan-1 lacking all three heparan sulfate at-
tachment sites (ARH-77–TDM) were unable to attach to
rADAM 12-cys (Fig. 4 C). Some of the syndecan-1 TDM
molecules do bear chondroitin sulfate chains (Langford et
al., 1998), but apparently cannot mediate cell attachment
to rADAM-cys. Together these data demonstrate that ad-
hesion of the ARH-77 cells to ADAM 12 is mediated by
heparan sulfate chains of syndecan.
The finding that glypican-1–expressing cells did not ad-
here to rADAM 12-cys indicated that cell surface hepa-
ran sulfate chains alone were not sufficient for adhesion
to rADAM 12-cys and suggested a role for the syndecan
core proteins. To examine this, we analyzed adhesion to
rADAM 12-cys of ARH-77 cells expressing various mu-
tant and chimeric forms of syndecan-1, including syn/279t
(syndecan-1 lacking its cytoplasmic tail), syn/glyp (a chi-
meric proteoglycan composed of the syndecan-1 extracel-
lular domain and a glycosyl phosphatidylinositol (GPI) an-
chor for attachment to the cell surfaces), and glyp/syn, (a
chimeric proteoglycan composed of the glypican extracel-
lular domain and the syndecan transmembrane and cyto-
plasmic domains). It has been shown previously that both
the mutant and chimeric forms of syndecan are capable of
binding ARH-77 cells to type I collagen and to fibronectin
(Liu et al., 1998; this study; not shown). Representative
syndecan-1 and glypican-1 cell surface immunostainings
are shown as insets in Fig. 4 D. However, none of these
mutant cell lines exhibited significant cell adhesion to
rADAM 12-cys (Fig. 4 D). Taken together these results
demonstrate that different syndecan family members can
mediate cell adhesion to rADAM 12-cys. Moreover, in ad-
dition to the critical role of heparan sulfate chains, both
the extracellular and cytoplasmic domains of the syndecan
core protein are required for the ADAM 12–mediated cell
adhesion process.
Having established the critical role of syndecans in
rADAM 12-cys–mediated cell adhesion, we wanted to ex-
plore which syndecans can be functional in the mesenchy-
mal cells. We examined RD rhabdomyosarcoma cells,
which express syndecans-1 (80 kD), syndecan-2 (50 kD),
and syndecan-4 (35 kD) based on RT-PCR and Western
blotting (Fig. 5, A and B). Cell surface biotinylated RD
cells were extracted and applied on an affinity-matrix to
which rADAM 12-cys had been immobilized. Elution of
bound material and subsequent gel separation and West-
Figure 3. Cell attachment on rADAM 12-cys is dependent on
cell surface heparan sulfate. (A) Cell attachment of SV-HFO
cells (filled bars) and MRC-5 (hatched bars) plated on rADAM
12-cys. (B) Cell attachment of SV-HFO cells (filled bars) plated
on rADAM 12-DC. The assays were performed in the presence
or absence of the reagents indicated (chlorate 20 mM and the
other reagents 10 mg/ml). Ordinates represent percentage adhe-
sion. Each point represents the mean 6 SEM of triplicate wells.
Figure 4. Cell attachment to rADAM 12-cys is mediated through
the syndecans. (A) Cell attachment of ARH-77 cells transfected
with either an empty vector (Neo), syndecan-1, -2, or -4 (Syn-1,
-2, or -4), or with glypican-1 (Glyp-1) and plated on rADAM 12-
cys (20 mg/ml) or in B, on rADAM 12-DC. (C) Cell attachment
on rADAM 12-cys of syndecan-1–expressing cells treated with
chlorate, heparin, heparan sulfate, chondroitin sulfate ABC
(Chon A1B1C), heparitinase (Hep-ase) or chondroitinase ABC
(Chon-ase ABC). ARH-77–TDM cells express syndecan-1 lack-
ing heparan sulfate attachment sites but with intact chondroitin
sulfate chains. (D) Cell attachment on rADAM 12-cys of ARH-
77 cells expressing truncated syndecan-1 (Syn/279t) or chimeric
proteoglycans (Syn/Glyp and Glyp/Syn). Each point represents
the mean 6 SEM of triplicate wells. Ordinates represent percent-
age of adhesion or OD values at 590 nm. Insets in D show synde-
can-1 cell surface immunostaining of the ARH-77 Syn/Glyp cells
(upper) and glypican-1 cell surface immunostaining of ARH-77
Glyp/Syn (lower). Bars, 22 mm.Iba et al. ADAM 12 in Cell Adhesion 1149
ern blotting showed a smear of an approximate Mr of
200,000 (Fig. 5 C, lane 1). After digestion, the material
with heparitinase, a sharp band of 35 kD, was seen (Fig. 5
C, lane 2). Syndecan-4 has a similar molecular mass and
the protein was identified in Western blotting using anti-
bodies specific for syndecan-4 (Fig. 5 C, lane 3). These re-
sults indicate syndecan-4 as one potential adhesion recep-
tor for rADAM 12-cys. Since solubilization of syndecans
required the use of urea in the extraction buffer (Hoffman
et al., 1998), we do not know whether syndecan-4 is the
sole syndecan used by the RD cells when they attach to
rADAM 12-cys.
The interaction between native human syndecan-4 and
rADAM 12-cys was confirmed in a solid-phase binding as-
say (Fig. 5, D and E). As demonstrated in Fig. 5 E,
rADAM 12-cys exhibited significant syndecan-4 binding,
similar to that of bFGF. Thus, when 800 cpm of 125I-labeled
human syndecan-4 (Fig. 5 D) was added in the assay (Fig.
5 E), an average of 224 cpm (6 7.1) bound to bFGF, 105
cpm (6 15.1) bound to rADAM 12-cys, and 5 cpm (6 3.1)
to BSA. Heparitinase treatment of syndecan-4 completely
destroyed its ability to bind to both rADAM 12-cys and
bFGF, demonstrating that the heparan sulfate glycosami-
noglycan chains were crucial for binding of these two
ligands.
Full-Length Human rADAM 12-GFP Binds to 
Syndecan-expressing Cells But Not to Cells Lacking 
Cell Surface Syndecans
The results presented so far were obtained using rADAM
12-cys made in E. coli or rADAM 12-DC made in insect
cells. To confirm the interaction of full-length ADAM 12
with cell surface syndecans, we generated a GFP-tagged
form of ADAM 12-S expressed in COS-7 cells. Culture
medium from these cells was collected and mixed with
ARH-77 cells expressing syndecans or control ARH-77
cells that do not express syndecans. After a 1-h incubation
at 48C or at 378C, ARH-77 cells were examined by fluores-
cence microscopy. Distinct punctate cell surface fluores-
cence was observed on the syndecan-expressing cells but
not on control cells (Fig. 6, A, B, and D). No fluorescence
was observed when the syndecan-expressing ARH-77 cells
were pretreated with heparitinase or when heparin was in-
cluded in the medium, or when the cells were incubated
with medium containing GFP without ADAM 12-S (Fig.
6, C–E). These data support the model that ADAM 12
binds to cell surfaces primarily via syndecans.
Integrin b1 Is Involved in Cell Spreading
When mesenchymal cells were treated with function-
blocking mAbs to b1 integrin (AIIB2 and P5D2) the cells
attached but no longer spread on rADAM 12-cys (Fig. 7,
B–D). More than 90% of these cells had a rounded mor-
phology with several fine 7–10-mm long cytoplasmic pro-
jections without organized focal adhesions and stress fi-
bers. In parallel experiments, these antibodies inhibited
cell attachment of RKO colon carcinoma cells to laminin-1
and -10 (not shown), confirming the function-blocking ac-
tivity of the preparation of purified mAbs used. As a fur-
ther control, we tested a control IgG and found that this
mAb had no effect on cell attachment and spreading (not
shown). The data shown represent experiments done with
the SV-HFO cell line and are representative of the inhibi-
tory effect of function-blocking b1 integrin mAbs on the
spreading of the other mesenchymal cells used in this
study. Finally, we examined cell spreading of SV-HFO,
MRC-5, IMR-90, and RD cells that had been treated for
3 h before the experiment with 25 mg/ml cycloheximide to
inhibit protein synthesis. Such treatment had no effect on
cell attachment and spreading on rADAM 12-cys (not
shown), indicating that cells bind and spread on the sup-
plied rADAM 12-cys and not to substances secreted by
the cells during the assay period.
To provide further evidence that integrin b1 is involved
in rADAM 12–mediated spreading, we used genetically
modified cells. Integrin b1–null mice are early embryonal
Figure 5. Syndecan-4 binds to rADAM 12-cys. (A) RT-PCR
demonstrates the expression of syndecan-1 (lane 2), -2 (lane 3),
and -4 (lane 4) transcripts by the RD cells. Lane 1 is a negative
control. (B) RD cell extracts were separated by DEAE Sephacel,
treated with heparitinase and chondroitinase resolved by SDS-
PAGE, and membranes probed with the pan-syndecan antibody
that recognizes the conserved C2 region in the cytoplasmic do-
mains of all the syndecan family members (lane 1) or a preim-
mune serum (lane 2). (C) SDS-PAGE of syndecan-4 from RD
cells isolated by rADAM 12-cys affinity chromotography. Lane 1
shows a smeared band with an apparent Mr 200,000. After treat-
ment with heparitinase, a single distinct band with an apparent
Mr 35,000 (lane 2) is seen. A polyclonal antibody to syndecan-4
identified this band as syndecan-4 (lane 3). (D) Purified iodi-
nated syndecan-4 before (lane 1) and after (lane 2) removal of
the heparan sulfate glycosaminoglycan side chains by heparati-
nase treatment. (E) Solid phase binding assay demonstrating that
syndecan-4 binds bFGF and rADAM 12-cys (filled bars) and that
treatment of syndecan-4 with heparitinase completely inhibits its
binding to rADAM 12-cys (hatched bars).The Journal of Cell Biology, Volume 149, 2000 1150
lethal, precluding establishment of defined b1 integrin2/2
cell populations in culture (Fässler and Meyer, 1995;
Stephens et al., 1995). To overcome this problem, we
established chondroblasts from conditional b1 integrin
knock-out mice (Potocnik, A.J., C. Brakebusch, and R.
Fässler, manuscript submitted for publication), immor-
talized them with simian virus 40 large T antigen, and
subsequently deleted the b1 integrin by a cre recombi-
nase transfection as described in Materials and Methods.
Chondroblast1c/1c cells attached, and .90% of the cells
spread on rADAM 12-cys and laminin-1, respectively (Fig.
8, A and B). Chondroblast2/2 cells attached on rADAM
12-cys, but their spreading was significantly reduced (Fig.
8 C). As expected, b1 integrin–null chondroblasts did not
attach on laminin-1 (Fig. 8 D). Moreover, we confirmed
that both chondroblast1c/1c and 2/2 cell attachment to
rADAM 12-cys was completely inhibited by heparin (Fig.
8 E). The lack of detectable b1 integrin expression on the
surface of 2/2 chondroblasts was confirmed by FACS
analysis (Fig. 8 F).
Multiple Integrin a Subunits Are Involved in Cell 
Spreading on rADAM 12-cys
To determine which integrin a chain(s) were involved in
cell spreading, we used a series of function-blocking mAbs
in the attachment assays. No effect on cell attachment or
cell spreading was observed with function-blocking anti-
bodies to integrin a1, a2, a3, a5, and a6 when added indi-
vidually (not shown). When administered in pairs of two
mAbs, integrin a3 and a5, a3 and a6, and a5 and a6 mAbs
had no effect on cell attachment, but a partial (z30%) in-
hibitory effect on cell spreading (not shown). Other com-
binations were without effect on cell spreading. Finally,
when integrin a3, a5, and a6 mAbs were combined, 90%
inhibition of cell spreading was seen (Fig. 9). These results
suggest that multiple integrin a subunits participate in cell
spreading on rADAM 12-cys.
Syndecan–b1 Integrin Cross-talk Is Nonfunctional in 
Carcinoma Cells
Our data suggested that mesenchymal cells use syndecans
as the primary cell attachment receptor to rADAM 12-cys,
and use b1 integrin to mediate cell spreading. However, in
a previous report, we found that carcinoma cells had a
rounded morphology and did not spread upon attaching to
rADAM 12-cys (Iba et al., 1999). We therefore tested
whether cell spreading could be induced (Fig. 10). Addi-
tion of either Mn21 or b1 integrin–activating antibodies
changes the conformation of the extracellular domain of
b1 integrins to an active ligand-binding state by increasing
the apparent affinity (Hynes, 1992; Humphries, 1996).
Carcinoma cells were plated on laminin-1, fibronectin,
rADAM 12-cys, or rADAM 12-DC for 30 min, followed
Figure 6. Full-length human ADAM 12 binds to syndecan-
expressing cells. ARH-77 cells were incubated with ADAM
12-GFP–containing medium for 1 h at 48C and examined by fluo-
rescence microscopy. (A) Distinct cell surface fluorescence is ob-
served along the cell surface of ARH-77 cells transfected with
syndecan-1, but (B) no cell surface fluorescence is seen in control
ARH-77 cells transfected with vector only. (C) Secreted GFP
(not linked to ADAM 12) did not bind to syndecan-1–expressing
cells, and (D) no fluorescence was observed when the cells had
been pretreated with heparitinase. Phase contrast of the control
ARH-77 neo cells examined in B is shown in E. Bars, 20 mm.
Figure 7. Cell spreading in response to rADAM
12-cys is mediated by b1 integrin. (A) Cell at-
tachment of SV-HFO cells with the characteristic
spread morphology is shown. (B–D) In the pres-
ence of function-blocking mAbs to b1 integrin
(AIIB2), the cells attached but no longer spread,
and displayed a rounded morphology with many
cytoplasmic projections. Three representative
fields are shown. Bars: 10 mm (A, B, and D); and
12 mm (C).Iba et al. ADAM 12 in Cell Adhesion 1151
by another 30-min incubation in the presence or absence
of Mn21. Carcinoma cells adhered tightly on laminin-1 and
fibronectin and were well-spread. The addition of Mn21 or
b1 integrin–activating antibodies neither increased the
number of adherent cells nor the extent of spreading (Fig.
10, A, B, and I). In contrast, when cells were plated on
rADAM 12-cys or rADAM 12-DC they adhered well but
were not spread (Fig. 10, C and G). Addition of 1 mM
Mn21 or b1 integrin–activating antibodies induced im-
mediate spreading (Fig. 10, D, F, and H), which was simi-
lar to cells plated on laminin or fibronectin. No effect was
seen when the control K20 b1 integrin mAb was added
(Fig. 10 E).
Discussion
The data obtained in this study demonstrate that the
rADAM 12-cys and rADAM 12-DC serve as potent adhe-
sion substrates for a variety of mesenchymal cells, includ-
ing lines of fibroblastic, osteoblastic, and myoblastic cell
origin. Furthermore, rADAM 12-GFP binds to the cell
surface. In the adhesion process, syndecan and integrin
cell surface receptors act cooperatively to generate signals
for cell adhesion and cell spreading, and for the assembly
of focal adhesions and actin stress fibers. Syndecans are in-
volved in cell attachment and b1 integrins in the subse-
quent cell spreading. Interestingly, carcinoma cells attach
but fail to spread on rADAM 12-cys and rADAM 12-DC.
Their spreading, however, can be efficiently induced by
addition of either 1 mM Mn21 or the b1 integrin–activat-
ing mAb 12G10. These data support a model in which the
binding of cell surface syndecans with the ADAM 12 cys-
teine-rich domain leads to an integrin-dependent spread-
ing of cells. Interestingly, in carcinoma cells, the binding to
rADAM 12-cys by syndecans does not allow the integrin-
mediated cell spreading. The signaling machinery involved
in this syndecan–integrin cross-talk is unknown.
Syndecans are abundant cell surface heparan sulfate
proteoglycans involved in multiple biological processes
by virtue of the binding of their glycosaminoglycans to
growth factors, extracellular matrix proteins, cell adhesion
molecules, and proteases and protease inhibitors (Carey,
1997; Rapraeger and Ott, 1998; Woods et al., 1998; Bern-
field et al., 1999; Zimmermann and David, 1999). It is cal-
culated that heparan sulfate proteoglycans occupy .25%
of the cell surface of many cells (Lander, 1999). The hepa-
ran sulfate chains, which are attached to the ectodomain of
the core protein, have a strong negative charge and inter-
act with proteins by forming multiple electrostatic contacts
with basic amino acids. This interaction usually leads to
relatively low affinity binding (dissociation constants in
the range of 2 3 1028 – 2 3 1025 M) (Lander, 1998). In this
study, low concentrations of heparin (10–20 mg/ml) com-
pletely blocked the interaction of mesenchymal cells with
immobilized rADAM 12-cys and rADAM 12-DC, and
pretreatment of the cells with heparitinase likewise inhib-
ited the interaction. Moreover, if cells were incubated with
chlorate, an inhibitor of sulfation, no adhesion was ob-
served. Finally, cells that do not contain cell surface hepa-
ran sulfates do not attach to rADAM 12-cys. This was
shown with ARH-77 cells that express very little cell sur-
face heparan sulfate and with several ARH-77 transfec-
tants used as a model system to examine which cell surface
heparan proteoglycan supports rADAM 12-cys–mediated
cell adhesion. ARH-77 cell lines transfected with either
syndecan-1, -2, or -4 attached to rADAM 12-cys, whereas
cells transfected with glypican-1 did not, demonstrating
Figure 8. b1 integrin–deficient chondroblasts attach but do not
spread on rADAM 12-cys. (A and B) Cell attachment of b1 inte-
grin chondroblasts (1c/1c) plated on rADAM 12-cys and lami-
nin-1, respectively. (C and D) Cell attachment of b1 integrin2/2
chondroblasts on rADAM 12-cys and laminin-1, respectively.
Bars, 14 mm. (E) Chondroblast cell attachment (filled bars) and
the effect of 10 mg/ml of heparin (hatched bars) on rADAM 12-
cys or laminin-1 as a substrate. The substrate concentration was
20 mg/ml. Ordinate represents OD values at 590 nm. (F) FACS
analysis confirming the absence of b1 integrin on 2/2 chondro-
blasts.The Journal of Cell Biology, Volume 149, 2000 1152
that different syndecan members are able to mediate cell
adhesion to rADAM 12-cys.
The syndecan family consists of four members, desig-
nated syndecans 1–4. Each syndecan shows a specific and
distinct expression pattern during development and in
adult tissue (Carey, 1997; Rapraeger and Ott, 1998; Woods
et al., 1998; Bernfield et al., 1999; Zimmermann and
David, 1999). Syndecan-1 is primarily expressed on epithe-
lial cells, syndecan-2 (fibroglycan) on fibroblastic, endo-
thelial, and liver cells, and syndecan-3 (N-syndecan) on
neuronal cells. Syndecan-4 (ryudocan, amphiglycan) shows
a widespread expression pattern. In addition, syndecan-4
is specifically concentrated into focal adhesions with inte-
grins, and may play an important role in the control of fo-
cal adhesion formation and the organization of the actin
cytoskeleton (Woods and Couchman, 1994; Baciu and
Goetinck, 1995; Echtermeyer et al., 1999; Longley et al.,
1999). However, many cells express more than one synde-
can (Kim et al., 1994). To test the idea that one syndecan
might be preferentially used by specific cell types in the
process of cell adhesion to rADAM 12-cys, we isolated
proteins from biotinylated RD cell surfaces that bind to
rADAM 12-cys by affinity chromatography. Indeed, syn-
decan-4 with a core protein of z35 kD bound detectably
to immobilized rADAM 12-cys. A solid phase binding
assay devised previously by Kojima et al. (1996) confirmed
the interaction of purified human syndecan-4 with rADAM
12-cys. Thus, syndecan-4 represents a potentially impor-
tant binding partner for ADAM 12 in the cell adhesion re-
sponse described here and possibly also in modulating cell
behavior in myogenesis (Yagami-Hiromasa et al., 1995;
Gilpin et al., 1998) and cancer (Iba et al., 1999).
Syndecans often serve as coreceptors. The classical ex-
ample is that syndecans supply the glycosaminoglycans
necessary for bFGF to bind to its high affinity receptor
(Rapraeger et al., 1991). More recently, several reports
have pointed to a role for syndecans, in particular synde-
can-4, as coreceptors for integrins (Woods et al., 1986; Sa-
oncella et al., 1999). We also show in our study that both
syndecans and integrins are involved in rADAM 12-cys–
mediated cell attachment and spreading. The initial cell at-
tachment is mediated by syndecans, and subsequent cell
spreading by functional b1 integrins. This conclusion is
based on the observation that cells treated with function-
blocking antibodies to integrin b1 and cells in which the b1
integrin gene was deleted attach to rADAM 12-cys but do
not spread. Mesenchymal cells express several b1 inte-
grins. For example, SV-HFO osteoblastic cells express b1,
a1–a3 and a5–a6, and avb3 (Iba et al., 1996). A combina-
tion of function-blocking antibodies reacting with a3, a5,
and a6 integrins inhibited cell spreading. Whereas treat-
ment of cells with antibodies in pairs showed partial inhibi-
tion of spreading, single antibody treatment had no effect.
These data clearly suggest that syndecan and integrins co-
operate during cell adhesion and spreading.
Integrins have been identified previously as receptors
for the ADAMs and for the closely related snake venom
metalloproteases (SVMPs). Several SVMPs interact with
aIIbb3 and a2b1 integrins, and through this binding com-
pete with their natural ligands, causing severe hemorrhage
in the bite victim (Jia et al., 1996). In the mouse, ADAM 2
(fertilin b) on the sperm cell surface interacts through the
disintegrin-like domain with a6b1 integrin on eggs in the
fertilization process (Almeida et al., 1995; Chen et al.,
1999a,b). The importance of ADAM 2 in this process is
also supported by the finding that mice deficient of
ADAM 2 are infertile (Cho et al., 1998). Further evidence
for a role of the disintegrin-like domain in cellular interac-
tions was provided by Zhang et al. (1998) and Nath et al.
(1999). Thus, the Arg-Gly-Asp (RGD)-containing disinte-
grin-like domain of ADAM 15 made in E. coli interacts
with the avb3 integrin (Zhang et al., 1998). ADAM 15
made in COS cells as a chimeric protein containing the ex-
tracellular domain of ADAM 15 fused to the Fc portion of
human IgG interacts with avb3 and a5b1 integrins on dif-
ferent hemopoietic cells. We have demonstrated that
rADAM 12-cys and rADAM 12-DC support cell adhesion
(Iba et al., 1999; Zolkiewska, 1999; this study). Further-
more, we show here that full-length ADAM 12 (rADAM
12-GFP) binds to cell surface syndecans. Based on these
results, it appears that the cysteine-rich domain of ADAM
12 comprises most of the syndecan-mediated cell binding ac-
tivity. Interestingly, the cysteine-rich domain of the hemor-
rhagic SVMP atrolysin A has been recently demonstrated
to inhibit collagen-stimulated platelet aggregation, indica-
tive of an interaction with integrin a2b1 (Jia et al., 2000).
Thus, for ADAM 12, and possibly for other ADAMs and
SVMPs, the cysteine-rich domain is involved in mediating
cellular interactions via syndecans and integrins.
Integrins regulate many cellular events, including shape,
adhesion, migration, and survival of cells. The execution of
these functions depends on the activation state of inte-
Figure 9. Multiple integrins
are involved in rADAM 12-
cys–mediated cell spreading.
(A) MRC-5 cells plated on
rADAM 12-cys had a spread
and flattened morphology.
(B) In contrast, cells treated
with function-blocking mAbs
to a3 1 a5 1 a6 integrins at-
tached but did not spread.
Note the rounded cell mor-
phology with numerous cyto-
plasmic projections. Bars: 22
mm (A); and 26 mm (B).Iba et al. ADAM 12 in Cell Adhesion 1153
grins. In recent years, several laboratories have shown that
integrins can be expressed on the cell surface but are un-
able to recognize and bind their ligands. Certain signals
such as the activation of R-ras (Zhang et al., 1996) and the
phosphorylation of integrin cytoplasmic domain–asso-
ciated protein-1 (ICAP-1) (Bouvard and Block, 1998) or
the focal adhesion protein VASP (vasodilator-stimulated
phosphoprotein) (Aszodi et al., 1999) may change the con-
formation of integrins and thereby modulate the ability to
bind ligands. These changes are referred to as inside-out
signaling. The data presented in this paper suggest a model
in which the initial binding of ADAM 12 cysteine-rich do-
main by syndecan on mesenchymal cells triggers a confor-
mational change of the ADAM 12-cys, which may allow
integrins to bind ADAM 12-cys and subsequently the cells
to spread. This hypothesis is supported by several findings.
First, blocking antibodies to integrins inhibit spreading of
mesenchymal cells on rADAM 12-cys. Secondly, chondro-
Figure 10. Carcinoma cells can be induced to
spread by activating the b1 integrins. RKO colon
carcinoma cells were allowed to attach to laminin
(A and B), rADAM 12-cys (C–F), or rADAM
12-DC (G and H) for 30 min followed by the ad-
dition of reagents known to stimulate b1 integrin
activity. RKO cells were plated on laminin either
in the absence (A) or in the presence (B) of 1
mM Mn21. RKO cells were plated on rADAM
12-cys in the absence (C), or presence (D) of 1
mM Mn21, or in the presence of control b1 inte-
grin mAb K20 (10 mg/ml) (E), or the b1 integrin–
activating mAb 12G10 (10 mg/ml) (F). Similarly
RKO cells were plated on rADAM 12-DC in the
absence (G) or presence (H) of 1 mM Mn21. Bar,
12 mm. (I) RKO cell attachment (filled bars) and
the effect of 1 mM Mn21 (hatched bars) on
rADAM 12-cys, rADAM 12-DC, laminin-1, or
fibronectin as substrates (20 mg/ml). Ordinate
represents OD values at 590 nm.The Journal of Cell Biology, Volume 149, 2000 1154
blasts which lack the expression of b1 integrin fail to
spread on rADAM 12-cys. Thirdly, carcinoma cells can
tightly bind to rADAM 12-cys, but in contrast to mesen-
chymal cells, are unable to spread on rADAM 12-cys. The
inability to spread can be efficiently overcome by either
adding activating antibodies or Mn21, which both can
change the conformation of the integrins and allow inte-
grin binding. The inability of carcinoma cells to spread on
rADAM 12-cys adds another twist to our findings. It sug-
gests that in carcinoma cells, the binding of rADAM 12-cys
to syndecan may lead to an inactivation of integrins through
syndecan-mediated signals that consequently does not al-
low the integrins to bind to rADAM 12-cys. Alternatively,
the binding of rADAM 12-cys to syndecan may fail to sig-
nal positively to the integrins in the carcinoma cells. Sev-
eral questions need to be addressed in the future. It will be
interesting to see whether the cross-talk between synde-
cans and integrins is only operating in transformed carci-
noma cells or also in primary epithelial cells. Furthermore,
we do not know why syndecan signaling to integrins is dif-
ferent between mesenchymal cells and carcinoma cells.
Work addressing these interesting questions is currently in
progress in our laboratory.
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